Article
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Hepatology (Baltimore, Md.) - 1 Dec 1998
Payen J L, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski J P, Seigneurin J M, Dussaix E, Voigt J J, Selves J, Barange K, Puel J, Pascal J P
Abstract excerpt
We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months...
Topics
- Adult
- Alanine Transaminase
- Antiviral Agents
- Drug Administration Schedule
- Female
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferon alpha-2
- Interferon-alpha
- Male
- Middle Aged